Trial Profile
Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites; Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2016 New trial record